INS and metabolic dysfunction-associated steatotic liver disease: It has been demonstrated that ceramides could inhibit insulin signaling and induce oxidation stress and inflammation, which participated in NAFLD development (Marí and Fernández-Checa, 2007; Gill and Sattar, 2009), although the mechanistic link between hepatic steatosis and ceramide remains unclear.